Suppr超能文献

抗氧化剂溶液与血管紧张素-(1-7)联合应用对 Langendorff 灌注大鼠心脏提供心肌保护。

Antioxidant Solution in Combination with Angiotensin-(1-7) Provides Myocardial Protection in Langendorff-Perfused Rat Hearts.

机构信息

Department of Cardio-Thoracic and Vascular Surgery, Klinikum Klagenfurt am Wörthersee, 9020 Klagenfurt, Austria.

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, 8010 Graz, Austria.

出版信息

Oxid Med Cell Longev. 2020 Jul 30;2020:2862631. doi: 10.1155/2020/2862631. eCollection 2020.

Abstract

As progressive organ shortage in cardiac transplantation demands extension of donor criteria, effort is needed to optimize graft survival. Reactive oxygen and nitrogen species, generated during organ procurement, transplantation, and reperfusion, contribute to acute and late graft dysfunction. The combined application of diverse substances acting via different molecular pathways appears to be a reasonable approach to face the complex mechanism of ischemia reperfusion injury. Thus, an antioxidant solution containing -ketoglutaric acid, 5-hydroxymethylfurfural, -acetyl-L-methionine, and -acetyl-selenium-L-methionine was combined with endogenous angiotensin-(1-7). Its capacity of myocardial protection was investigated in isolated Langendorff-perfused rat hearts subjected to warm and cold ischemia. The physiological cardiac parameters were assessed throughout the experiments. Effects were evaluated via determination of the oxidative stress parameters malondialdehyde and carbonyl proteins as well as immunohistochemical and ultrastructural tissue analyses. It was shown that a combination of 20% (/) antioxidant solution and 220 pM angiotensin-(1-7) led to the best results with a preservation of heart tissue against oxidative stress and morphological alteration. Additionally, immediate cardiac recovery (after warm ischemia) and normal physiological performance (after cold ischemia) were recorded. Overall, the results of this study indicate substantial cardioprotection of the novel combination with promising prospective for future clinical use.

摘要

随着心脏移植中不断增加的器官短缺,需要努力优化移植物的存活率。在器官获取、移植和再灌注过程中产生的活性氧和氮物种,导致急性和晚期移植物功能障碍。联合应用通过不同分子途径发挥作用的多种物质似乎是应对缺血再灌注损伤复杂机制的合理方法。因此,一种含有 -酮戊二酸、5-羟甲基糠醛、-乙酰-L-蛋氨酸和 -乙酰-硒-L-蛋氨酸的抗氧化溶液与内源性血管紧张素-(1-7)结合使用。在经历热缺血和冷缺血的离体 Langendorff 灌流大鼠心脏中,研究了其心肌保护能力。在整个实验过程中评估了生理心脏参数。通过测定氧化应激参数丙二醛和羰基蛋白以及免疫组织化学和超微结构组织分析来评估效果。结果表明,20%(/)抗氧化溶液和 220 pM 血管紧张素-(1-7)的组合效果最佳,可保护心脏组织免受氧化应激和形态改变的影响。此外,还记录了心脏在热缺血后的即时恢复(after warm ischemia)和在冷缺血后的正常生理功能(after cold ischemia)。总的来说,这项研究的结果表明,这种新组合具有显著的心脏保护作用,具有未来临床应用的广阔前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3611/7415103/06d9390dca02/OMCL2020-2862631.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验